lakeland semaglutide Weight-loss drug Wegovy available in Canada starting May 6 for people with obesity Quick N Save Pharmacy |
Description
Injectables may remain preferred for patients needing maximum weight reduction
Personal results and responses to GLP-1 medications can vary
After the official market entry of "Semaglutide for weight loss " (Novo Nordisk's Wegovy) in November, another important member of the semaglutide familyoral semaglutide , Rybelsusis set to take center stage in clinical practice
Discontinuation rates due to adverse effects were also higher with retatrutide being 16-17% compared with 2% with dulaglutide and 0-4% with placebo
